| 摘要 |
A novel process for the production of 2,2'cyclocytidine compounds and pharmaceutically acceptable salts thereof comprises reacting a 2',3'-O-dialkylstannylene cytidine compound with an amine in the presence of a sulfonyl compound. 2,2'-Cyclocytidine is a percursor to cytarabine, a known antineoplastic and antiviral agent.
|
